Life Extension Final Clerance Sale

Constipation References

Disease Prevention and Treatment, 5th edition

The references on this page correspond with the print version of Disease Prevention and Treatment, 5th edition. Since we continuously update the protocols online in response to new scientific developments, readers are encouraged to review the latest versions of the protocols.

  1. Arce DA, Ermocilla CA, et al. Evaluation of constipation. Am Fam Physician. 2002 Jun 1;65(11):2283-90.
  2. Rao SS. Constipation: evaluation and treatment. GastroenterolClin North Am. 2003 Jun;32(2):659-83.
  3. Hsieh C. Treatment of constipation in older adults. Am Fam Physician. 2005 Dec 1;72(11):2277-84.
  4. Whitehead WE, Drinkwater D, et al. Constipation in the elderly living at home: definition, prevalence, and relationship to lifestyle and health status. J Am Geriatr Soc. 1989 May;37(5):423-9.
  5. Simren M. Physical activity and the gastrointestinal tract.Eur J GastroenterolHepatol. 2002 Oct;14(10):1053-6.
  6. Muller-Lissner S. General geriatrics and gastroenterology: constipation and faecal incontinence. Best Pract Res ClinGastroenterol. 2002 Feb;16(1):115-33.
  7. Corazziari E. Definition and epidemiology of functional gastrointestinal disorders. Best Pract Res ClinGastroenterol. 2004 Aug;18(4):613-31.
  8. Voskuijl WP, Heijmans J, et al. Use of Rome II criteria in childhood defecation disorders: applicability in clinical and research practice. J Pediatr. 2004 Aug;145(2):213-7.
  9. Whitehead WE, Bassotti G, et al. Factor analysis of bowel symptoms in US and Italian populations. Dig Liver Dis. 2003 Nov;35(11):774-83.
  10. Sakakibara R, Odaka T, et al. Colonic transit time, sphincter EMG, and rectoanalvideomanometry in multiple system atrophy. MovDisord. 2004 Aug;19(8):924-9.
  11. Chiarelli P, Brown W, et al. Constipation in Australian women: prevalence and associated factors. IntUrogynecol J Pelvic Floor Dysfunct. 2000;11(2):71-8.
  12. Pfenninger JL, Zainea GG. Common anorectal conditions, part I: symptoms and complaints. Am Fam Physician. 2001 Jun 15;63(12):2391-8.
  13. Wald A. Constipation, diarrhea, and symptomatic hemorrhoids during pregnancy.GastroenterolClin North Am. 2003 Mar;32(1):309-22, vii.
  14. Sarpel U, Jacob BP, et al. Reduction of a large incarcerated rectal prolapse by use of an elastic compression wrap. Dis Colon Rectum. 2005 Jun;48(6):1320-2.
  15. Chen GD, Hu SW, et al. Prevalence and correlations of anal incontinence and constipation in Taiwanese women. NeurourolUrodyn. 2003;22(7):664-9.
  16. Slavin JL. Dietary fiber: classification, chemical analyses, and food sources. J Am Diet Assoc. 1987 Sep;87(9):1164-71.
  17. Marlett JA, McBurney MI, Slavin JL. Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc. 2002 Jul;102(7):993-1000.
  18. Marsicano LJ, Berrizbeitia ML, et al. Use of glucomannan dietary fiber in changes in intestinal habit [in Spanish]. G E N. 1995 Jan-Mar;49(1):7-14.
  19. Signorelli P, Croce P, et al. [A clinical study of the use of a combination of glucomannan with lactulose in the constipation of pregnancy.] Minerva Ginecol. 1996 Dec;48(12):577-82.
  20. Benton JM, O'Hara PA, et al. Changing bowel hygiene practice successfully: a program to reduce laxative use in a chronic care hospital. GeriatrNurs. 1997 Jan;18(1):12-7.
  21. Klaschik E, Nauck F, et al. Constipation: modern laxative therapy. Support Care Cancer. 2003 Nov;11(11):679-85.
  22. Pietrusko RG. Use and abuse of laxatives. Am J Hosp Pharm. 1977 Mar;34(3):291-300.
  23. Rousseau P. Treatment of constipation in the elderly. Postgrad Med. 1988 Mar;83(4):339-5, 349.
  24. Yakabowich M. Prescribe with care: the role of laxatives in the treatment of constipation. J GerontolNurs. 1990 Jul;16(7):4-11.
  25. McRorie JW, Daggy BP, et al. Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment PharmacolTher. 1998 May;12(5):491-7.
  26. Doughty DB.When fiber is not enough: current thinking on constipation management.Ostomy Wound Manage. 2002 Dec;48(12):30-41.
  27. Schiller LR. New and emerging treatment options for chronic constipation. Rev GastroenterolDisord. 2004;4(suppl 2):S43-S51.
  28. Joo JS, Ehrenpreis ED, et al. Alterations in colonic anatomy induced by chronic stimulant laxatives: the cathartic colon revisited. J ClinGastroenterol. 1998 Jun;26(4):283-6.
  29. Phillips C, Polakoff D, et al. Assessment of constipation management in long-term care patients. J Am Med Dir Assoc. 2001 Jul-Aug;2(4):149-54.
  30. Coremans G, Kerstens R, et al. Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief: results of a double-blind, placebo-controlled clinical trial. Digestion. 2003;67(1-2):82-9.
  31. Emmanuel AV, Roy AJ, et al. Prucalopride, a systemic enterokinetic, for the treatment of constipation. Aliment PharmacolTher. 2002 Jul;16(7):1347-56.
  32. Sloots CE, Poen AC, et al. Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation. Aliment PharmacolTher. 2002 Apr;16(4):759-67.
  33. Farup PG, Bytzer P. Tegaserod: merely a laxative? Scand J Gastroenterol. 2004 Apr;39(4):404-5.
  34. Fisher RS, Thistle J, et al. Tegaserod does not alter fasting or meal-induced biliary tract motility. Am J Gastroenterol. 2004 Jul;99(7):1342-9.
  35. Johanson JF, Wald A, et al. Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial. ClinGastroenterolHepatol. 2004 Sep;2(9):796-805.
  36. Rigo J. Role of food fiber in nutrition [in Russian].VoprPitan. 1982 Jul-Aug;(4):26-30.
  37. Sipos P, Hagymasi K, et al. Effects of black radish root (Raphanussativus L. varniger) on the colon mucosa in rats fed a fat rich diet. Phytother Res. 2002 Nov;16(7):677-9.
  38. Grigoleit HG, Grigoleit P. Peppermint oil in irritable bowel syndrome. Phytomedicine. 2005 Aug;12(8):601-6.
  39. Tanaka R, Shimosaka K. Investigation of the stool frequency in elderly who are bed ridden and its improvements by ingesting bifidus yogurt [in Japanese]. Nippon Ronen IgakkaiZasshi. 1982 Nov;19(6):577-82.
  40. Ouwehand AC, Langstrom H, et al. Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann NutrMetab. 2002;46(3-4):159-62.
  41. Agrawal A, Houghton LA, Morris J, et al. Clinical trial: the effects of a fermented milk product containing Bifidobacteriumlactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment PharmacolTher. 2009 Jan;29(1):104-14.
  42. Guglielmetti S, Mora D, Gschwender M, Popp K. Randomised clinical trial: Bifidobacteriumbifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study. Aliment PharmacolTher. 2011 May;33(10):1123-32.
  43. Guyonnet D, Woodcock A, Stefani B, Trevisan C, Hall C. Fermented milk containing Bifidobacteriumlactis DN-173 010 improved self-reported digestive comfort amongst a general population of adults. A randomized, open-label, controlled, pilot study.J Dig Dis. 2009 Feb;10(1):61-70.
  44. Ringel-Kulka T, Palsson OS, Maier D, et al. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacteriumlactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study. J ClinGastroenterol.2011 Jul;45(6):518-25.
  45. Kleessen B, Sykura B, et al. Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am J ClinNutr. 1997 May;65(5):1397-402.